D. Western Therapeutics Institute, Inc. (TYO:4576)
Japan flag Japan · Delayed Price · Currency is JPY
96.00
+1.00 (1.05%)
Mar 27, 2026, 3:30 PM JST

TYO:4576 Income Statement

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
387471428448414
Revenue Growth (YoY)
-17.83%10.05%-4.46%8.21%16.62%
Cost of Revenue
3947362821
Gross Profit
348424392420393
Selling, General & Admin
298265258255248
Research & Development
6691,367930469316
Operating Expenses
9681,6341,190726565
Operating Income
-620-1,210-798-306-172
Interest Expense
-8-5-2-3-4
Interest & Investment Income
2----
Currency Exchange Gain (Loss)
7163317
Other Non Operating Income (Expenses)
-12-13-2-20-
EBT Excluding Unusual Items
-631-1,227-796-296-159
Gain (Loss) on Sale of Investments
---12-100-
Gain (Loss) on Sale of Assets
--2---
Asset Writedown
---6--
Legal Settlements
----44-
Other Unusual Items
--60-12--
Pretax Income
-631-1,289-826-440-159
Income Tax Expense
11111
Earnings From Continuing Operations
-632-1,290-827-441-160
Minority Interest in Earnings
--151212
Net Income
-632-1,290-812-429-148
Net Income to Common
-632-1,290-812-429-148
Shares Outstanding (Basic)
4835323029
Shares Outstanding (Diluted)
4835323029
Shares Change (YoY)
36.48%10.51%7.22%1.04%7.96%
EPS (Basic)
-13.19-36.73-25.55-14.47-5.05
EPS (Diluted)
-13.19-36.73-25.55-14.47-5.05
Free Cash Flow
-495-1,308-598-363-178
Free Cash Flow Per Share
-10.33-37.24-18.82-12.25-6.07
Gross Margin
89.92%90.02%91.59%93.75%94.93%
Operating Margin
-160.21%-256.90%-186.45%-68.30%-41.55%
Profit Margin
-163.31%-273.88%-189.72%-95.76%-35.75%
Free Cash Flow Margin
-127.91%-277.71%-139.72%-81.03%-42.99%
EBITDA
-573-1,161-750-260-127
EBITDA Margin
-148.06%-246.50%-175.23%-58.04%-30.68%
D&A For EBITDA
4749484645
EBIT
-620-1,210-798-306-172
EBIT Margin
-160.21%-256.90%-186.45%-68.30%-41.55%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.